The potential value of the neutral comet assay and the expression of genes associated with DNA damage in assessing the radiosensitivity of tumor cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 748, Issue 1-2, 2012, Pages 52-59

  Jayakumar, Sundarraj ^a   Bhilwade, Hari N ^a   Pandey, Badri N ^a   Sandur, Santosh K ^a   Chaubey, Ramesh C ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Comet assay; DNA damage; Ionizing radiation; Predictive assay; Radiosensitivity

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; FAS ANTIGEN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HEAT SHOCK PROTEIN 70; PROTEIN; PROTEIN BCL 2; PROTEIN KU80; PROTEIN MCL 1; PROTEIN MDM2; PUMA PROTEIN; RAD51 PROTEIN; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CLONOGENIC ASSAY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; GAMMA RADIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

CELL LINE; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; GENE EXPRESSION; HUMANS; NEOPLASMS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RADIATION TOLERANCE;

EID: 84865044015     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.06.008     Document Type: Article

References (31)

1. Peters L.J. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother. Oncol. 1990, 17:177-190. The ESTRO Regaud lecture.
2. West C.M., Davidson S.E., Roberts S.A., Hunter R.D. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br. J. Cancer 1997, 76:1184-1190.
3. Bjork-Eriksson T., West C., Karlsson E., Mercke C. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46:13-19.
4. Torres-Roca J.F., Eschrich S., Zhao H., Bloom G., Sung J., McCarthy S., Cantor A.B., Scuto A., Li C., Zhang S., Jove R., Yeatman T. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res. 2005, 65:7169-7176.
5. Olive P.L., Banath J.P. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:331-335.
6. Crompton N.E., Ozsahin M. A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat. Res. 1997, 147:55-60.
7. Severin E., Greve B., Pascher E., Wedemeyer N., Hacker-Klom U., Silling G., Kienast J., Willich N., Gohde W. Evidence for predictive validity of blood assays to evaluate individual radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:242-250.
8. Folkvord S., Flatmark K., Dueland S., de Wijn R., Groholt K.K., Hole K.H., Nesland J.M., Ruijtenbeek R., Boender P.J., Johansen M., Giercksky K.E., Ree A.H. Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78:555-562.
9. McKenna D.J., McKeown S.R., McKelvey-Martin V.J. Potential use of the comet assay in the clinical management of cancer. Mutagenesis 2008, 23:183-190.
10. McKeown S.R., Robson T., Price M.E., Ho E.T., Hirst D.G., McKelvey-Martin V.J. Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation. Br. J. Cancer 2003, 89:2264-2270.
11. Moneef M.A., Sherwood B.T., Bowman K.J., Kockelbergh R.C., Symonds R.P., Steward W.P., Mellon J.K., Jones G.D. Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity. Br. J. Cancer 2003, 89:2271-2276.
12. Nahas S.A., Davies R., Fike F., Nakamura K., Du L., Kayali R., Martin N.T., Concannon P., Gatti R.A. Comprehensive profiling of radiosensitive human cell lines with DNA damage response assays identifies the neutral comet assay as a potential surrogate for clonogenic survival. Radiat. Res. 2012, 177:176-186.
13. Olive P.L., Banath J.P., MacPhail H.S. Lack of a correlation between radiosensitivity and DNA double-strand break induction or rejoining in six human tumor cell lines. Cancer Res. 1994, 54:3939-3946.
14. Muller W.U., Bauch T., Streffer C., Niedereichholz F., Bocker W. Comet assay studies of radiation-induced DNA damage and repair in various tumour cell lines. Int. J. Radiat. Biol. 1994, 65:315-319.
15. Jayakumar S., Bhilwade H.N., Dange P.S., Sarma H.D., Chaubey R.C., Pandey B.N. Magnitude of radiation-induced DNA damage in peripheral blood leukocytes and its correlation with aggressiveness of thymic lymphoma in Swiss mice. Int. J. Radiat. Biol. 2011, 87:1113-1119.
16. Burlinson B., Tice R.R., Speit G., Agurell E., Brendler-Schwaab S.Y., Collins A.R., Escobar P., Honma M., Kumaravel T.S., Nakajima M., Sasaki Y.F., Thybaud V., Uno Y., Vasquez M., Hartmann A. Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2007, 627:31-35.
17. Yu Y., Zhu W., Diao H., Zhou C., Chen F.F., Yang J. A comparative study of using comet assay and γH2AX foci formation in the detection of N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA damage. Toxicol. In Vitro 2006, 20:959-965.
18. Kunwar A., Jayakumar S., Bhilwade H.N., Bag P.P., Bhatt H., Chaubey R.C., Priyadarsini K.I. Protective effects of selenocystine against gamma-radiation-induced genotoxicity in Swiss albino mice. Radiat. Environ. Biophys. 2011, 50:271-280.
19. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:e36.
20. Lee Y.S., Oh J.H., Yoon S., Kwon M.S., Song C.W., Kim K.H., Cho M.J., Mollah M.L., Je Y.J., Kim Y.D., Kim C.D., Lee J.H. Differential gene expression profiles of radioresistant non-small-cell lung cancer cell lines established by fractionated irradiation: tumor protein p53-inducible protein 3 confers sensitivity to ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77:858-866.
21. Carlson D.J., Keall P.J., Loo B.W., Chen Z.J., Brown J.M. Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79:1188-1195.
22. Shankar B., Kumar S.S., Sainis K.B. Generation of reactive oxygen species and radiation response in lymphocytes and tumor cells. Radiat. Res. 2003, 160:478-487.
23. Zhong Y.-H., Liao Z.-K., Zhou F.-X., Xie C.-H., Xiao C.-Y., Pan D.-F., Luo Z.-G., Liu S.-Q., Zhou Y.-F. Telomere length inversely correlates with radiosensitivity in human carcinoma cells with the same tissue background. Biochem. Biophys. Res. Commun. 2008, 367:84-89.
24. El-Awady R.A., Dikomey E., Dahm-Daphi J. Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks. Br. J. Cancer 2003, 89:593-601.
25. Elkind M.M., Sutton-Gilbert H., Moses W.B., Alescio T., Swain R.W. Radiation response of mammalian cells grown in culture. V. Temperature dependence of the repair of X-ray damage in surviving cells (aerobic and hypoxic). Radiat. Res. 1965, 25:359-376.
26. Moeller B.J., Yordy J.S., Williams M.D., Giri U., Raju U., Molkentine D.P., Byers L.A., Heymach J.V., Story M.D., Lee J.J., Sturgis E.M., Weber R.S., Garden A.S., Ang K.K., Schwartz D.L. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clin. Cancer Res. 2011, 17:2035-2043.
27. Collis S.J., Tighe A., Scott S.D., Roberts S.A., Hendry J.H., Margison G.P. Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res. 2001, 29:1534-1538.
28. Ohnishi T., Taki T., Hiraga S., Arita N., Morita T. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem. Biophys. Res. Commun. 1998, 245:319-324.
29. Tambini C.E., Spink K.G., Ross C.J., Hill M.A., Thacker J. The importance of XRCC2 in RAD51-related DNA damage repair. DNA Repair 2010, 9:517-525.
30. Du X.L., Jiang T., Wen Z.Q., Gao R., Cui M., Wang F. Silencing of heat shock protein 70 expression enhances radiotherapy efficacy and inhibits cell invasion in endometrial cancer cell line. Croat. Med. J. 2009, 50:143-150.
31. Niu P., Liu L., Gong Z., Tan H., Wang F., Yuan J., Feng Y., Wei Q., Tanguay R.M., Wu T. Overexpressed heat shock protein 70 protects cells against DNA damage caused by ultraviolet C in a dose-dependent manner. Cell Stress Chaperones 2006, 11:162-169.